Trial for Alterity’s neurodegenerative drug ATH434 shows reduced disability
Alterity Therapeutics Ltd (ASX:ATH) has reported positive interim results from its Phase…
Alterity Therapeutics Limited (ASX:ATH)
About Alterity Therapeutics Limited
Key Information
ATH In the News
ASX Announcements
| Date | Announcement | File | Views |
|---|---|---|---|
| 14/03/2025 | Application for quotation of securities - ATH | 15.63KB | 429 |
| 13/03/2025 | Becoming a substantial holder | 944.45KB | 5.1K |
| 28/02/2025 | Notice of Extraordinary General Meeting/Proxy Form | 469.1KB | 493 |
| 28/02/2025 | Price Sensitive PS Half Yearly Report and Accounts | 709.07KB | 421 |
| 24/02/2025 | Proposed issue of securities - ATH | 16.95KB | 862 |
| 19/02/2025 | Change in substantial holding | 476.17KB | 618 |
| 17/02/2025 | Notice Under Section 708A | 105.51KB | 527 |
| 17/02/2025 | Application for quotation of securities - ATH | 15.97KB | 349 |